Transcend Medical Gets $22M

Menlo Park-based Transcend Medical, a developer of micro-stents used to treat glaucoma, has raised $22M in a Series C funding. The company said the funding came from existing investors, as well as an un-named, global pharmaceutical and medical device company. The firm said the funding will go to support clinical trials. The firm's prior investors include mag, Split Rock Partners, Canaan Partners, Investor Growth Capital, Technology Partners, HLM Venture Partners, Latterell Venture Partners, Kaiser Permanente Ventures, and Finistere Ventures. More information »